시장보고서
상품코드
1193077

셀룰라이트 치료 시장 : 시술 유형별, 셀룰라이트 유형별, 최종 사용자별 - 세계 기회 분석 및 산업 예측(2021-2031년)

Cellulite Treatment Market By Procedure Type, By Cellulite Type, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

발행일: | 리서치사: Allied Market Research | 페이지 정보: 영문 290 Pages | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

전세계 셀룰라이트 치료 시장은 2021년에 21억 4000만 달러, 2031년에는 57억 2906만 달러에 이를 것으로 예측되며, 2022년부터 2031년까지의 CAGR은 10.3%를 기록했다.

셀룰라이트는 섬유성 결합 조직 내의 피하 지방의 탈장으로 피부의 움푹 들어간 곳이나 결절로 나타나며 골반부(특히 엉덩이), 하지, 복부 등에 많이 보입니다. 이 증상은 여성에서 많이 나타납니다.

패스트 푸드 소비와 앉기 쉬운 라이프 스타일로 인한 비만 증가는 시장 성장을 이끌고 있습니다. 체중 증가와 고지방은 셀룰 라이트의 발생에 관여합니다. 또한 미용시술의 증가와 미용클리닉의 증가도 시장의 성장에 기여하고 있습니다. 예를 들어 국제미용정형외과학회(ISAPS)의 조사에 따르면 2020년에는 세계에서 약 10,129,528건의 미용외과 수술이 실시되고 있습니다. 소셜 미디어의 영향과 젊은 세대들에게 인기 있는 유명인들 덕분에 남성과 여성 모두 매력적인 외모에 대한 수요가 높아지고, 미적으로 매력적으로 보이도록 동기 부여되고 시장 성장을 위한 충분한 기회 를 제공합니다. 셀룰라이트 치료는 특히 허벅지와 엉덩이 주위에서 지방의 침착을 감소시키고 외관을 더욱 향상시킵니다.

침습성이 낮은 미용 성형 수술의 수요 증가, 미용 성형 수술의 인기 상승, 주로 여성의 유전적 요인은 시장 성장에 기여하고 있습니다. 첨단 비침습적 셀룰라이트 치료에 대한 인지도 향상, 미용 외과 의사의 수의 급증은 향후 몇 년 동안 시장 성장을 촉진 할 것으로 예상됩니다.

게다가 주요 선수들에 의한 첨단 셀룰라이트 치료의 개발, 제품 승인, 시장에서의 신규 제품 출시를 위한 연구개발 활동의 증가가 시장 성장을 추진하고 있습니다. 예를 들어, 2020년 7월 고도에 초점을 맞춘 전문 브랜드 및 제네릭 의약품 회사인 Endo International plc는 성인 여성의 엉덩이의 중등도에서 중증 셀룰라이트 치료를 위한 Qwo(콜라게나제 클로스트리듐 히스트릭 -aaes)에 대해 미국 식품의약국(FDA) 승인을 받았습니다. 그러나 첨단 셀룰라이트 치료에는 비용이 많이 들고 신흥국에서는 의료 인프라가 발달되지 않기 때문에 시장 성장을 방해할 수 있습니다.

목차

제1장 소개

제2장 주요 요약

제3장 시장 개요

  • 시장의 정의와 범위
  • 주요 조사 결과
    • 주요 투자 포켓
  • Porter's Five Forces 분석
  • 주요 기업의 포지셔닝
  • 시장 역학
    • 촉진 요인
    • 억제 요인
    • 기회
  • COVID-19 영향 분석

제4장 셀룰라이트 치료 시장 : 치료법 유형별

  • 개요
    • 시장 규모 및 예측
  • 비침습성
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별
  • 저침습
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별
  • 국소 마취
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별

제5장 셀룰라이트 치료 시장 : 셀룰라이트 유형별

  • 개요
    • 시장 규모 및 예측
  • 연질 셀룰라이트
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별
    • 연질 셀룰라이트·셀룰라이트 치료 시장 : 성별
      • 남성 시장 규모·예측 : 지역별
      • 여성 시장 규모·예측 : 지역별
  • 경질 셀룰라이트
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별
    • 경질 셀룰라이트의 셀룰라이트 치료 시장 : 성별
      • 남성 시장 규모·예측 : 지역별
      • 여성 시장 규모 추이·예측 : 지역별
  • 부종성
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별

제6장 셀룰라이트 치료 시장 : 최종 사용자별

  • 개요
    • 시장 규모·예측
  • 병원
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별
  • 클리닉, 뷰티 센터
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별
  • 기타
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별

제7장 셀룰라이트 치료 시장 : 지역별

  • 개요
    • 시장 규모·예측
  • 북미
    • 주요 동향과 기회
    • 북미 시장 규모·예측 : 시술 유형별
    • 북미의 시장 규모·예측 : 셀룰라이트 유형별
      • 북미의 연질 셀룰라이트·셀룰라이트 치료 시장 : 성별
      • 북미의 경질 셀룰라이트·셀룰라이트 치료 시장 : 성별
    • 북미의 시장 규모·예측 : 엔드유저별
    • 북미 시장 규모·예측 : 국가별
      • 미국
      • 캐나다
      • 멕시코
  • 유럽
    • 주요 동향과 기회
    • 유럽 시장 규모·예측 : 시술 유형별
    • 유럽의 시장 규모·예측 : 셀룰라이트 유형별
      • 유럽의 연질 셀룰라이트·셀룰라이트 치료 시장 : 성별
      • 유럽 경질 셀룰라이트·셀룰라이트 치료 시장 : 성별
    • 유럽 시장 규모·예측 : 최종 사용자별
    • 유럽 시장 규모·예측 : 국가별
      • 독일
      • 프랑스
      • 영국
      • 이탈리아
      • 스페인
      • 기타 유럽 지역
  • 아시아태평양
    • 주요 동향과 기회
    • 아시아태평양의 시장 규모·예측 : 시술 유형별
    • 아시아태평양의 시장 규모·예측 : 셀룰라이트 유형별
      • 아시아태평양의 연질 셀룰라이트·셀룰라이트 치료 시장 : 남녀별
      • 아시아태평양의 경질 셀룰라이트·셀룰라이트 치료 시장 : 남녀별
    • 아시아태평양의 시장 규모·예측 : 최종 사용자별
    • 아시아태평양의 시장 규모·예측 : 국가별
      • 일본
      • 중국
      • 호주
      • 인도
      • 기타 아시아태평양
  • LAMEA
    • 주요 동향과 기회
    • LAMEA의 시장 규모·예측 : 시술 유형별
    • LAMEA의 시장 규모·예측 : 셀룰라이트 유형별
      • LAMEA의 연질 셀룰라이트·셀룰라이트 치료 시장 : 남녀별
      • LAMEA의 경질 셀룰라이트·셀룰라이트 치료 시장 : 남녀별
    • LAMEA의 시장 규모·예측 : 엔드유저별
    • LAMEA의 시장 규모·예측 : 국가별
      • 브라질
      • 사우디아라비아
      • 남아프리카
      • 기타 LAMEA

제8장 기업 정세

  • 소개
  • 주요 성공 전략
  • 주요 10개사의 제품 매핑
  • 경쟁 대시보드
  • 경합의 히트 맵
  • 주요 발전

제9장 기업 프로필

  • Abbvie Inc
  • Candela Syneron
  • Cynosure Technologies
  • Merz Pharma GmbH & Co. KGaA
  • Bausch Health Companies Inc.
  • Hologic Inc
  • Zimmer Aesthetics
  • Galderma SA
  • Sinclair Pharmaceuticals Limited
  • Endo International plc
ksm 23.03.27

The global cellulite treatment market was valued at $2,140.0 million in 2021, and is projected to reach $5,729.06 million by 2031, registering a CAGR of 10.3% from 2022 to 2031.

Cellulite is the herniation of subcutaneous fat within fibrous connective tissue that manifests as skin dimpling and nodularity, often on the pelvic region (specifically the buttocks), lower limbs, and abdomen. The condition is most prevalent in women.

The increase in obesity rate owing to fast food consumption and sedentary lifestyle drive the growth of the market. Weight gain and high obesity are responsible for the development of cellulites. In addition, the increase in the number of cosmetic procedures and the rise in a number of cosmetic clinics contribute toward the growth of the market. For instance, according to International Society of Aesthetic Plastic Surgery (ISAPS) survey, in 2020 about 10,129,528 cosmetic surgical procedures are carried worldwide. The rise in demand for attractive physical appearance in men and women owing to social media influence and celebrities who are popular among the young generation, motivate them to look aesthetically appealing, which provides ample opportunities for market growth. The cellulite treatment, reduces the fat depositions especially from around the thighs and buttocks which further enhances the appearance.

The increase in demand for minimally invasive cosmetic procedures, rise in popularity of cosmetic procedures and genetical factors predominantly in women contribute toward the market growth. Increase in awareness about advanced non-invasive cellulite treatment, and surge in number of cosmetology surgeons are expected to drive the market growth in the coming years.

Moreover, the increase in R&D activities for development of advanced cellulite treatment, product approvals and novel product launch in the market by key players boost the market growth. For instance, in July 2020, Endo International plc, a highly-focused specialty branded and generics pharmaceutical company, has received U.S. Food and Drug Administration (FDA) approval for its, Qwo (collagenase clostridium histolyticum-aaes) for the treatment of moderate to severe cellulite in the buttocks of adult women. However, the high cost of advanced cellulite treatment and underdeveloped health care infrastructure in developing countries may hinder the growth of the market.

The cellulite treatment market is segmented on the basis of procedure type, cellulite type, end user and region. By procedure type, the market is divided into non-invasive, minimal invasive and topical. By cellulite type, the market is classified into soft cellulite, hard cellulite, and edematous cellulite. The soft cellulite segment is further divided into male and female. The hard cellulite segment is further bifurcated into male and female. By end user, the market is categorized into hospitals, clinics & beauty centers, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in the report include ABBVIE, Bausch Health Companies Inc, Candela Syneron, Cynosure, Galderma SA, Johnson & Johnson, Merz Pharma GmbH & Co. KGaA, Sientra Inc, Sinclair Pharma and Teoxane Laboratories.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cellulite treatment market analysis from 2021 to 2031 to identify the prevailing cellulite treatment market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the cellulite treatment market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global cellulite treatment market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Procedure Type

  • Non-invasive
  • Minimally Invasive
  • Topical

By Cellulite Type

  • Soft Cellulite
    • Gender
    • Male
    • Female
  • Hard Cellulite
    • Gender
    • Male
    • Female
  • Edematous

By End User

  • Hospitals
  • Clinics and Beauty Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest Of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • Rest Of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest Of LAMEA
  • Key Market Players
    • Abbvie Inc
    • Candela Syneron
    • Cynosure Technologies
    • Merz Pharma GmbH & Co. KGaA
    • Bausch Health Companies Inc.
    • Hologic Inc
    • Zimmer Aesthetics
    • Galderma SA
    • Sinclair Pharmaceuticals Limited
    • Endo International plc

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Non-invasive
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
  • 4.3 Minimally Invasive
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country
  • 4.4 Topical
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market analysis by country

CHAPTER 5: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Soft Cellulite
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
    • 5.2.4 Soft Cellulite Cellulite Treatment Market by Gender
      • 5.2.4.1 Male Market size and forecast, by region
      • 5.2.4.2 Female Market size and forecast, by region
  • 5.3 Hard Cellulite
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
    • 5.3.4 Hard Cellulite Cellulite Treatment Market by Gender
      • 5.3.4.1 Male Market size and forecast, by region
      • 5.3.4.2 Female Market size and forecast, by region
  • 5.4 Edematous
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country

CHAPTER 6: CELLULITE TREATMENT MARKET, BY END USER

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Hospitals
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
  • 6.3 Clinics and Beauty Centers
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country
  • 6.4 Others
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market analysis by country

CHAPTER 7: CELLULITE TREATMENT MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Procedure Type
    • 7.2.3 North America Market size and forecast, by Cellulite Type
      • 7.2.3.1 North America Soft Cellulite Cellulite Treatment Market by Gender
      • 7.2.3.2 North America Hard Cellulite Cellulite Treatment Market by Gender
    • 7.2.4 North America Market size and forecast, by End User
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Market size and forecast, by Procedure Type
      • 7.2.5.1.2 Market size and forecast, by Cellulite Type
      • 7.2.5.1.3 Market size and forecast, by End User
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Market size and forecast, by Procedure Type
      • 7.2.5.2.2 Market size and forecast, by Cellulite Type
      • 7.2.5.2.3 Market size and forecast, by End User
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Market size and forecast, by Procedure Type
      • 7.2.5.3.2 Market size and forecast, by Cellulite Type
      • 7.2.5.3.3 Market size and forecast, by End User
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Procedure Type
    • 7.3.3 Europe Market size and forecast, by Cellulite Type
      • 7.3.3.1 Europe Soft Cellulite Cellulite Treatment Market by Gender
      • 7.3.3.2 Europe Hard Cellulite Cellulite Treatment Market by Gender
    • 7.3.4 Europe Market size and forecast, by End User
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Market size and forecast, by Procedure Type
      • 7.3.5.1.2 Market size and forecast, by Cellulite Type
      • 7.3.5.1.3 Market size and forecast, by End User
      • 7.3.5.2 France
      • 7.3.5.2.1 Market size and forecast, by Procedure Type
      • 7.3.5.2.2 Market size and forecast, by Cellulite Type
      • 7.3.5.2.3 Market size and forecast, by End User
      • 7.3.5.3 UK
      • 7.3.5.3.1 Market size and forecast, by Procedure Type
      • 7.3.5.3.2 Market size and forecast, by Cellulite Type
      • 7.3.5.3.3 Market size and forecast, by End User
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Market size and forecast, by Procedure Type
      • 7.3.5.4.2 Market size and forecast, by Cellulite Type
      • 7.3.5.4.3 Market size and forecast, by End User
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Market size and forecast, by Procedure Type
      • 7.3.5.5.2 Market size and forecast, by Cellulite Type
      • 7.3.5.5.3 Market size and forecast, by End User
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Market size and forecast, by Procedure Type
      • 7.3.5.6.2 Market size and forecast, by Cellulite Type
      • 7.3.5.6.3 Market size and forecast, by End User
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Procedure Type
    • 7.4.3 Asia-Pacific Market size and forecast, by Cellulite Type
      • 7.4.3.1 Asia-Pacific Soft Cellulite Cellulite Treatment Market by Gender
      • 7.4.3.2 Asia-Pacific Hard Cellulite Cellulite Treatment Market by Gender
    • 7.4.4 Asia-Pacific Market size and forecast, by End User
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 Japan
      • 7.4.5.1.1 Market size and forecast, by Procedure Type
      • 7.4.5.1.2 Market size and forecast, by Cellulite Type
      • 7.4.5.1.3 Market size and forecast, by End User
      • 7.4.5.2 China
      • 7.4.5.2.1 Market size and forecast, by Procedure Type
      • 7.4.5.2.2 Market size and forecast, by Cellulite Type
      • 7.4.5.2.3 Market size and forecast, by End User
      • 7.4.5.3 Australia
      • 7.4.5.3.1 Market size and forecast, by Procedure Type
      • 7.4.5.3.2 Market size and forecast, by Cellulite Type
      • 7.4.5.3.3 Market size and forecast, by End User
      • 7.4.5.4 India
      • 7.4.5.4.1 Market size and forecast, by Procedure Type
      • 7.4.5.4.2 Market size and forecast, by Cellulite Type
      • 7.4.5.4.3 Market size and forecast, by End User
      • 7.4.5.5 Rest of Asia-Pacific
      • 7.4.5.5.1 Market size and forecast, by Procedure Type
      • 7.4.5.5.2 Market size and forecast, by Cellulite Type
      • 7.4.5.5.3 Market size and forecast, by End User
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Procedure Type
    • 7.5.3 LAMEA Market size and forecast, by Cellulite Type
      • 7.5.3.1 LAMEA Soft Cellulite Cellulite Treatment Market by Gender
      • 7.5.3.2 LAMEA Hard Cellulite Cellulite Treatment Market by Gender
    • 7.5.4 LAMEA Market size and forecast, by End User
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Market size and forecast, by Procedure Type
      • 7.5.5.1.2 Market size and forecast, by Cellulite Type
      • 7.5.5.1.3 Market size and forecast, by End User
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Market size and forecast, by Procedure Type
      • 7.5.5.2.2 Market size and forecast, by Cellulite Type
      • 7.5.5.2.3 Market size and forecast, by End User
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Market size and forecast, by Procedure Type
      • 7.5.5.3.2 Market size and forecast, by Cellulite Type
      • 7.5.5.3.3 Market size and forecast, by End User
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Market size and forecast, by Procedure Type
      • 7.5.5.4.2 Market size and forecast, by Cellulite Type
      • 7.5.5.4.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 Abbvie Inc
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 Candela Syneron
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 Cynosure Technologies
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 Merz Pharma GmbH & Co. KGaA
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 Bausch Health Companies Inc.
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 Hologic Inc
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 Zimmer Aesthetics
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 Galderma SA
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 Sinclair Pharmaceuticals Limited
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 Endo International plc
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제